Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma

Clinical Biochemistry

Volumn 45, Issue 10-11, 2012, Pages 827-834

  Yonglitthipagon, Ponlapat ^a,b   Pairojkul, Chawalit ^a   Bhudhisawasdi, Vajarabhongsa ^a   Mulvenna, Jason ^b   Loukas, Alex ^b   Sripa, Banchob ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

Enolase; Cholangiocarcinoma; ENO1; Prognostic marker; Proteomics

Indexed keywords

ALPHA ENOLASE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AMINO ACID SEQUENCE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862567956     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.04.004     Document Type: Article

References (35)

1. Sripa B., Pairojkul C. Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol 2008, 24:349-356.
2. Jongsuksuntigul P., Imsomboon T. Opisthorchiasis control in Thailand. Acta Trop 2003, 88:229-232.
3. Sriamporn S., Pisani P., Pipitgool V., Suwanrungruang K., Kamsa-ard S., Parkin D.M. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health 2004, 9:588-594.
4. Sriamporn S., Parkin D.M., Pisani P., Vatanasapt V., Suwanrungruang K., Kamsa-ard P., et al. A prospective study of diet, lifestyle, and genetic factors and the risk of cancer in Khon Kaen Province, northeast Thailand: description of the cohort. Asian Pac J Cancer Prev 2005, 6:295-303.
5. Sripa B., Kaewkes S., Sithithaworn P., Mairiang E., Laha T., Smout M., et al. Liver fluke induces cholangiocarcinoma. PLoS Med 2007, 4:e201.
6. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., et al. A review of human carcinogens-part B: biological agents. Lancet Oncol 2009, 10:321-322.
7. Blechacz B., Gores G.J. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008, 48:308-321.
8. Olnes M.J., Erlich R. A review and update on cholangiocarcinoma. Oncology 2004, 66:167-179.
9. Pak J.H., Moon J.H., Hwang S.J., Cho S.H., Seo S.B., Kim T.S. Proteomic analysis of differentially expressed proteins in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products. J Cell Biochem 2009, 108:1376-1388.
10. Srisomsap C., Sawangareetrakul P., Subhasitanont P., Chokchaichamnankit D., Chiablaem K., Bhudhisawasdi V., et al. Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes. J Biomed Biotechnol 2010, 2010:437143.
11. Yonglitthipagon P., Pairojkul C., Chamgramol Y., Mulvenna J., Sripa B. Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker. Int J Parasitol 2010, 40:1203-1212.
12. Sripa B., Leungwattanawanit S., Nitta T., Wongkham C., Bhudhisawasdi V., Puapairoj A., et al. Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol 2005, 11:3392-3397.
13. Grubman S.A., Perrone R.D., Lee D.W., Murray S.L., Rogers L.C., Wolkoff L.I., et al. Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines. Am J Physiol 1994, 266:G1060-G1070.
14. Fedor H.L., De Marzo A.M. Practical methods for tissue microarray construction. Methods Mol Med 2005, 103:89-101.
15. van Diest P.J., van Dam P., Henzen-Logmans S.C., Berns E., van der Burg M.E., Green J., et al. A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group. J Clin Pathol 1997, 50:801-804.
16. Zhuang P.Y., Zhang J.B., Zhu X.D., Zhang W., Wu W.Z., Tan Y.S., et al. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor. Cancer 2008, 112:2740-2748.
17. Desmetz C., Bibeau F., Boissiere F., Bellet V., Rouanet P., Maudelonde T., et al. Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ. J Proteome Res 2008, 7:3830-3837.
18. Zhong L., Peng X., Hidalgo G.E., Doherty D.E., Stromberg A.J., Hirschowitz E.A. Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients. Cancer Detect Prev 2003, 27:285-290.
19. Huang H.Y., Li C.F., Fang F.M., Tsai J.W., Li S.H., Lee Y.T., et al. Prognostic implication of ezrin overexpression in myxofibrosarcomas. Ann Surg Oncol 2010, 17:3212-3219.
20. Bartholow T.L., Chandran U.R., Becich M.J., Parwani A.V. Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma. BMC Clin Pathol 2011, 11:1.
21. David C.J., Chen M., Assanah M., Canoll P., Manley J.L. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 2010, 463:364-368.
22. Tsai S.T., Chien I.H., Shen W.H., Kuo Y.Z., Jin Y.T., Wong T.Y., et al. ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. Eur J Cancer 2010, 46:1712-1723.
23. Zhang Y., Li M., Liu Y., Han N., Zhang K., Xiao T., et al. ENO1 protein levels in the tumor tissues and circulating plasma samples of non-small cell lung cancer patients. Zhongguo Fei Ai Za Zhi 2010, 13:1089-1093.
24. Hay M.M., Chen T.R., McClintock P., Reid Y. American type culture collection catalogue of cell lines and hybridomas 1988, American type culture collection, Rockville, Md. 6th ed.
25. Jolodar A., Fischer P., Bergmann S., Buttner D.W., Hammerschmidt S., Brattig N.W. Molecular cloning of an alpha-enolase from the human filarial parasite Onchocerca volvulus that binds human plasminogen. Biochim Biophys Acta 2003, 1627:111-120.
26. Bishop J.G., Corces V.G. The nucleotide sequence of a Drosophila melanogaster enolase gene. Nucleic Acids Res 1990, 18:191.
27. Oliva D., Barba G., Barbieri G., Giallongo A., Feo S. Cloning, expression and sequence homologies of cDNA for human gamma enolase. Gene 1989, 79:355-360.
28. Wu W., Tang X., Hu W., Lotan R., Hong W.K., Mao L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis 2002, 19:319-326.
29. Chang G.C., Liu K.J., Hsieh C.L., Hu T.S., Charoenfuprasert S., Liu H.K., et al. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes. Clin Cancer Res 2006, 12:5746-5754.
30. Hamaguchi T., Iizuka N., Tsunedomi R., Hamamoto Y., Miyamoto T., Iida M., et al. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma. Int J Oncol 2008, 33:725-731.
31. Altenberg B., Greulich K.O. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 2004, 84:1014-1020.
32. Sousa L.P., Brasil B.S., Silva Bde M, Nogueira S.V., Andrade A.A., Ferreira P.C., et al. Characterization of alpha-enolase as an interferon-alpha 2 alpha 1 regulated gene. Front Biosci 2005, 10:2534-2547.
33. Sousa L.P., Silva B.M., Brasil B.S., Nogueira S.V., Ferreira P.C., Kroon E.G., et al. Plasminogen/plasmin regulates alpha-enolase expression through the MEK/ERK pathway. Biochem Biophys Res Commun 2005, 337:1065-1071.
34. Jiang B.H., Agani F., Passaniti A., Semenza G.L. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 1997, 57:5328-5335.
35. Nathan H., Pawlik T.M., Wolfgang C.L., Choti M.A., Cameron J.L., Schulick R.D. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg 2007, 11:1488-1496. [discussion 96-7].